World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
17807
World Ranking
2908
National Ranking
119

Michael H. Kershaw publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael H. Kershaw sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 182 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael H. Kershaw D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael H. Kershaw sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael H. Kershaw is affiliated with the Peter MacCallum Cancer Centre in Australia and conducts research primarily in medicine, immunology and microbiology, and engineering. Their work significantly focuses on oncology, immunology, and biomedical engineering, with subfields in molecular biology and electrical and electronic engineering.

The core topics of Michael H. Kershaw's research include CAR-T cell therapy, nanowire synthesis and applications, immunotherapy and immune responses, viral infectious diseases and gene expression in insects, immune cell function and interaction, cancer immunotherapy and biomarkers, as well as advancements in semiconductor devices and circuit design.

Michael H. Kershaw has published multiple papers across several scientific journals. Notable recent publications include:

  • Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies, 2021, Journal for ImmunoTherapy of Cancer
  • T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models, 2023, Science Translational Medicine
  • Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment, 2020, Clinical & Translational Immunology
  • Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells, 2020, Clinical & Translational Immunology
  • Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers, 2021, Immunotherapy Advances

The publication venues where Michael H. Kershaw frequently publishes include Clinical & Translational Immunology, Regular and Young Investigator Award Abstracts, Cancers, Journal of Thoracic Disease, and Journal for ImmunoTherapy of Cancer.

They collaborate regularly with several researchers, including Clare Y. Slaney, Phillip K. Darcy, Amanda J. Oliver, Bianca von Scheidt, and Aaron J Harrison.

Best Publications

  • Natural Innate and Adaptive Immunity to Cancer

    Matthew D. Vesely;Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth;Mark J. Smyth

  • A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

    Michael H. Kershaw;Michael H. Kershaw;Michael H. Kershaw;Jennifer A. Westwood;Jennifer A. Westwood;Linda L. Parker;Gang Wang;Gang Wang

  • Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells

    Liza B John;Christel Devaud;Connie P M Duong;Carmen S M Yong

  • Gene-engineered T cells for cancer therapy

    Michael H Kershaw;Jennifer A Westwood;Phillip K Darcy;Phillip K Darcy

  • Activating and inhibitory receptors of natural killer cells.

    Hollie J Pegram;Daniel M Andrews;Mark J Smyth;Phillip K Darcy

  • Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia.

    David S. Ritchie;Paul J. Neeson;Paul J. Neeson;Amit Khot;Stefan Peinert

  • Cytokines in cancer immunity and immunotherapy

    Mark J. Smyth;Erika Cretney;Michael H. Kershaw;Yoshihiro Hayakawa

  • Trafficking of T Cells into Tumors

    Clare Y. Slaney;Clare Y. Slaney;Michael H. Kershaw;Phillip K. Darcy

  • Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking.

    Yuekang Xu;Yuekang Xu;Yifan Zhan;Andrew M. Lew;Shalin H. Naik;Shalin H. Naik

  • Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.

    Michael H. Kershaw;Gang Wang;Jennifer A. Westwood;Russell K. Pachynski

  • Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity.

    A J Davenport;R S Cross;R S Cross;K A Watson;Y Liao

  • Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

    Paul A. Beavis;Paul A. Beavis;Nicole Milenkovski;Nicole Milenkovski;Melissa A. Henderson;Melissa A. Henderson;Liza B. John;Liza B. John

  • A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation.

    Mandy J. Ludford-Menting;Jane Oliaro;Faruk Sacirbegovic;Eric T.-Y. Cheah

  • Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

    Paul A. Beavis;Paul A. Beavis;Melissa A. Henderson;Melissa A. Henderson;Lauren Giuffrida;Lauren Giuffrida;Jane K. Mills;Jane K. Mills

  • CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment

    Clare Y Slaney;Pin Wang;Phillip K Darcy;Phillip K Darcy;Michael H Kershaw;Michael H Kershaw

  • Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

    Christel Devaud;Liza B John;Jennifer A Westwood;Phillip K Darcy

  • Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

    Nicole M Haynes;Joseph A Trapani;Michèle W L Teng;Jacob T Jackson

  • CAR T-cell therapy of solid tumors.

    Carmen S M Yong;Valerie Dardalhon;Christel Devaud;Naomi Taylor

  • Autoimmunity associated with immunotherapy of cancer.

    Sally M. Amos;Connie P. M. Duong;Jennifer A. Westwood;David S. Ritchie

  • Supernatural T cells: genetic modification of T cells for cancer therapy

    Michael H. Kershaw;Michele W. L. Teng;Mark J. Smyth;Phillip K. Darcy

Frequent Co-Authors

Phillip K. Darcy
Phillip K. Darcy Peter MacCallum Cancer Centre
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Paul A. Beavis
Paul A. Beavis Peter MacCallum Cancer Centre
Michele W. L. Teng
Michele W. L. Teng QIMR Berghofer Medical Research Institute
David Ritchie
David Ritchie Peter MacCallum Cancer Centre
Sherene Loi
Sherene Loi Peter MacCallum Cancer Centre
H. Miles Prince
H. Miles Prince Peter MacCallum Cancer Centre
Andrew M. Scott
Andrew M. Scott La Trobe University
Ricky W. Johnstone
Ricky W. Johnstone Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers where understanding the immune system is crucial. For those interested in fast-tracking into nursing, exploring the easiest absn programs to get into can provide a quick pathway to becoming a registered nurse with a strong foundation in immunological principles applied in clinical settings.

Entry-level opportunities are also available through the easiest lpn programs to get into, ideal for students aiming for practical nursing roles that often involve patient care relating to immune health and infectious diseases.

For advanced practice, the easiest np programs to get into offer pathways to become nurse practitioners who play a key role in immunology-related healthcare services, including disease prevention and immunization management.

Specialized fields such as mental health nursing also intersect with immunology. The best psychiatric mental health nurse practitioner programs online provide excellent clinical training opportunities for those interested in how immune function can influence psychiatric conditions.

Best Scientists Citing Michael H. Kershaw

Trending Scientists

Recently Published Articles